| |
Acute Myocardial Infarction in patients presenting with ST-segment elevation (Management of)
ESC Clinical Practice Guidelines
Topics:
Acute Coronary Syndromes (ACS)
Current versions available to download
Current translated versions available to download:
AuthorsFrans Van de Werf FESC, Chairperson, Jeroen Bax FESC, Amadeo Betriu FESC, Carina Blomstrom-Lundqvist FESC, Filippo Crea FESC, Volkmar Falk, Gerasimos Filippatos FESC, Keith Fox FESC, Kurt Huber FESC, Adnan Kastrati FESC, Annika Rosengren FESC, P. Gabriel Steg FESC, Marco Tubaro FESC, Freek Verheugt FESC, Franz Weidinger FESC, Michael Weis.
Endorsed by:
|
Table of contents: Full Text (ESC Clinical Practice Guidelines)
|
|
|
Introduction
|
The definition of acute myocardial infarction, The pathogenesis of ST-segment elevation acute myocardial infarction,The natural history of STEMI
|
First medical contact and emergency care flow
|
Initial diagnosis and early risk stratification, Relief of pain, breathlessness, and anxiety, Cardiac arrest
|
Pre-hospital or early in-hospital care
|
Restoring coronary flow and myocardial tissue reperfusion:
Percutaneous coronary interventions, Fibrinolytic treatment, Antithrombotic therapy without reperfusion therapy, Prevention and treatment of microvascular obstruction and reperfusion injury, Coronary bypass surgery
Pump failure and shock:
Clinical features, Mild heart failure (Killip class II), Severe heart failure and shock (Killip class III and IV)
Mechanical complications:
Cardiac rupture and mitral regurgitation, Cardiac rupture, Mitral regurgitation
Arrhythmias and conduction disturbances in the acute
phase:
Ventricular arrhythmias, Supraventricular arrhythmias, Sinus bradycardia and heart block
Routine prophylactic therapies in the acute phase:
Antithrombotic agents: aspirin, clopidogrel, and antithrombins, Antiarrhythmic drugs, b-Blockers, Nitrates, Calcium antagonists, Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers, Magnesium, Glucose–insulin–potassium
Management of specific types of infarction:
Right ventricular infarction, Myocardial infarction in diabetic patients, Patients with renal dysfunction
|
Management of the later in-hospital course
|
Ambulation
Management of specific in-hospital complications:
Deep vein thrombosis and pulmonary embolism, Intraventricular thrombus and systemic emboli, Pericarditis, Late ventricular arrhythmias, Post-infarction angina and ischaemia
|
Risk assessment
|
Indications and timing, Assessment of myocardial viability, Evaluation of risk of arrhythmia for prevention of
sudden death |
Rehabilitation and pre-discharge advice
|
Psychological and socio-economic aspects, Lifestyle advice, Physical activity |
Secondary prevention
|
Smoking cessation, Diet, dietary supplements, and weight control, Physical activity, Antiplatelet and anticoagulant treatment, b-Blockers, Calcium antagonists, Nitrates, Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers, Aldosterone blockade, Blood pressure control, Management of diabetes,
Interventions on lipid profile, Influenza vaccination, Cardiac resynchronization therapy, Prophylactic implantation of an implantable cardioverter–defibrillator |
Logistics of care
|
Pre-hospital care
Patient delay, Emergency medical system, Public education in cardiopulmonary resuscitation, The ambulance service, Networks, General practitioners, Admission procedures
The Intensive Cardiac Care Unit:
Non-invasive monitoring, Invasive monitoring
The post-discharge period
|
Gaps in evidence
|
|
Previous versions
| 2003 |
European Heart Journal 2003; 24:28-66 |
Full Text  |
| 1996 |
European Heart Journal 1996 ;17:43–63 |
Full Text |
A complete list of ESC Clinical Practice Guidelines (current and previous versions) endorsed by ESC National Society Members is available here.
|
|